Jack Botting

829 total citations
37 papers, 574 citations indexed

About

Jack Botting is a scholar working on Pharmacology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jack Botting has authored 37 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 7 papers in Molecular Biology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jack Botting's work include Inflammatory mediators and NSAID effects (12 papers), Neuropeptides and Animal Physiology (6 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). Jack Botting is often cited by papers focused on Inflammatory mediators and NSAID effects (12 papers), Neuropeptides and Animal Physiology (6 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). Jack Botting collaborates with scholars based in United Kingdom, Canada and United States. Jack Botting's co-authors include John R. Vane, R Salzmann, Regina M. Botting, Adrian R. Morrison, Adebayo Oyekan, A Gibson, Howard A. Bern, M. Ginsburg, M.J.A. Walker and Kathleen M. Johnston and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and British Journal of Pharmacology.

In The Last Decade

Jack Botting

36 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jack Botting United Kingdom 13 177 129 92 81 78 37 574
J. R. Vane United Kingdom 9 161 0.9× 140 1.1× 61 0.7× 114 1.4× 102 1.3× 17 598
Jacek Spławiński Poland 16 275 1.6× 195 1.5× 43 0.5× 122 1.5× 54 0.7× 45 718
M J Daly United Kingdom 14 77 0.4× 209 1.6× 116 1.3× 103 1.3× 75 1.0× 30 524
Karl H. Sanders Germany 11 74 0.4× 335 2.6× 117 1.3× 63 0.8× 80 1.0× 20 806
Anne Wu United States 13 131 0.7× 206 1.6× 60 0.7× 79 1.0× 79 1.0× 19 651
Stephen A. Ballard United Kingdom 15 157 0.9× 493 3.8× 82 0.9× 135 1.7× 47 0.6× 26 1.4k
V A Alabaster United Kingdom 15 106 0.6× 379 2.9× 197 2.1× 172 2.1× 32 0.4× 24 749
Michael A. Koss United States 18 115 0.6× 244 1.9× 90 1.0× 101 1.2× 376 4.8× 25 871
William L. West United States 15 55 0.3× 155 1.2× 53 0.6× 51 0.6× 20 0.3× 45 584
O. Heidenreich Germany 13 54 0.3× 187 1.4× 60 0.7× 78 1.0× 33 0.4× 75 561

Countries citing papers authored by Jack Botting

Since Specialization
Citations

This map shows the geographic impact of Jack Botting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack Botting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack Botting more than expected).

Fields of papers citing papers by Jack Botting

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack Botting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack Botting. The network helps show where Jack Botting may publish in the future.

Co-authorship network of co-authors of Jack Botting

This figure shows the co-authorship network connecting the top 25 collaborators of Jack Botting. A scholar is included among the top collaborators of Jack Botting based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack Botting. Jack Botting is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Botting, Jack. (2015). Animals and Medicine. Open Book Publishers. 6 indexed citations
2.
Botting, Jack. (2002). The history of thalidomide. Drug News & Perspectives. 15(9). 604–604. 51 indexed citations
3.
Botting, Regina M. & Jack Botting. (2000). Pathogenesis and Mechanisms of Inflammation and Pain. Clinical Drug Investigation. 19(Supplement 2). 1–7. 12 indexed citations
4.
Botting, Jack. (2000). Defining the role of COX-2 inhibitors in inflammatory and other diseases. Drug News & Perspectives. 13(9). 560–560. 12 indexed citations
5.
Botting, Jack. (1999). Nonsteroidal antiinflammatory agents. Drugs of today. 35(4-5). 225–225. 26 indexed citations
6.
Vane, John R. & Jack Botting. (1998). Selective COX-2 inhibitors : pharmacology, clinical effects, and therapeutic potential : proceedings of a conference held on March 20-21, 1997, in Cannes, France. Kluwer Academic eBooks. 3 indexed citations
7.
Botting, Jack & Adrian R. Morrison. (1997). Animal Research Is Vital to Medicine. Scientific American. 276(2). 83–85. 33 indexed citations
8.
Vane, John R., Jack Botting, & Regina M. Botting. (1996). Improved non-steroid anti-inflammatory drugs COX-2 enzyme inhibitors : proceedings of a conference held on October 10-11, 1995, at Regent's College, London. Kluwer Academic Publishers eBooks. 3 indexed citations
9.
Vane, John R., Jack Botting, & Regina M. Botting. (1996). Improved Non-Steroid Anti-Inflammatory Drugs: COX-2 Enzyme Inhibitors. 48 indexed citations
10.
Bazán, Nicolás G., Jack Botting, & John R. Vane. (1996). New targets in inflammation : inhibitors of COX-2 or adhesion molecules : proceedings of a conference held on April 15-16, 1996, in New Orleans, USA, supported by an educational grant from Boehringer Ingelheim. Medical Entomology and Zoology. 6 indexed citations
11.
Oyekan, Adebayo & Jack Botting. (1990). Indium-111 Oxine Technique of Studying Platelet Aggregation in vivo. Acta Haematologica. 83(2). 57–64. 4 indexed citations
12.
Oyekan, Adebayo, et al.. (1988). Cryptolepine inhibits platelet aggregation in vitro and in vivo and stimulates fibrinolysis ex vivo. General Pharmacology The Vascular System. 19(2). 233–237. 15 indexed citations
13.
Oyekan, Adebayo & Jack Botting. (1987). Inhibition of adenosine diphosphate-induced intravascular aggregation of rat platelets by 6-oxo-prostaglandin E1. Prostaglandins. 34(3). 359–366. 3 indexed citations
14.
Beijer, Lena, Jack Botting, Paul Crook, et al.. (1987). The involvement of platelet activating factor in endotoxin‐induced pulmonary platelet recruitment in the guinea‐pig. British Journal of Pharmacology. 92(4). 803–808. 32 indexed citations
15.
Botting, Jack & A Gibson. (1985). The mouse anococcygeus muscle as a preparation for the bioassay of oxytocin. Journal of Pharmacy and Pharmacology. 37(5). 348–349. 5 indexed citations
16.
Botting, Jack, Kathleen M. Johnston, Bernard A. MacLeod, & M.J.A. Walker. (1983). The effect of modification of sympathetic activity on responses to ligation of a coronary artery in the conscious rat. British Journal of Pharmacology. 79(1). 265–271. 34 indexed citations
17.
Botting, Jack. (1977). The mechanism of the release of prostaglandin-like activity from guinea-pig isolated ileum. Journal of Pharmacy and Pharmacology. 29(1). 708–709. 7 indexed citations
18.
Botting, Jack. (1975). SENSITIVITY OF NEONATAL RABBIT ILEUM TO HISTAMINE. British Journal of Pharmacology. 53(3). 428–429. 11 indexed citations
19.
Botting, Jack, et al.. (1969). Studies on the mode of action of vasopressin on the isolated proximal colon of the guinea‐pig. British Journal of Pharmacology. 37(1). 306–313. 4 indexed citations
20.
Botting, Jack. (1965). AN ISOLATED PREPARATION WITH A SELECTIVE SENSITIVITY TO VASOPRESSIN. British Journal of Pharmacology and Chemotherapy. 24(1). 156–162. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. R. Vane Breakdown of academic impact, for papers by Jacek Spławiński Breakdown of academic impact, for papers by M J Daly Breakdown of academic impact, for papers by Karl H. Sanders Breakdown of academic impact, for papers by Anne Wu Breakdown of academic impact, for papers by Stephen A. Ballard Breakdown of academic impact, for papers by V A Alabaster Breakdown of academic impact, for papers by Michael A. Koss Breakdown of academic impact, for papers by William L. West Breakdown of academic impact, for papers by O. Heidenreich
Rankless by CCL
2026